Skip to main content
OpenTrials

Clinical trial condition

Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors

Explore clinical trials studying Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors trial results

Recruiting

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

NCT05868629

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • Lundquist Inst BioMed at Harbor Torrance, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Johns Hopkins University Washington D.C., District of Columbia, United States
  • Duke Clinical Research Institute Durham, North Carolina, United States
View Trial Details

Related conditions